S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › CURA › Research report
← CURA page
XStocksXray
Market X-Ray report · 19 October 2026

Curaleaf Holdings Inc. (CURA)

Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026

Key indicators

Last closeCAD 10.78
52-week range7.77 – 20.92
Return, 1 month / 3 months−25.0% / −18.0%
Return, 1 year / 3 years−18.0% / −35.3%
TrendBelow its 200-day average
RSI (14)25
Volatility (1 year)99.5%
Worst drawdown (1 year)-59.3%
Average daily value traded4.94M CAD
Dividend yield–

Market X-Ray price-based

36/ 100 · High confidence · ahead of 25% of stocks on this exchange
Trend41
Momentum36
Stability (higher is calmer)9
Liquidity71
Income–

Five-year price chart navy: price · brown: 200-day average

0.8111.3121.8132.3142.812021-102023-012024-042025-072026-10

About the company

Curaleaf Holdings is a cannabis company that cultivates, processes and sells cannabis products. It offers dried flower, oils, edibles, vaporizers and related items under its own brands, and it runs retail dispensaries where customers can purchase these products. Its customers are adult consumers and patients in markets where cannabis is legal, and the company is based in the United States while its common equity trades on a Canadian exchange.

The shares are listed on the Toronto Exchange in Canada under the code CURA, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Curaleaf Holdings Inc. (CURA) trades on the Toronto Exchange in Canada. It last closed at CAD 10.78 on 19 October 2026.

Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 651 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 18.0% and over the last three months it fell 18.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Curaleaf Holdings Inc. (CURA)

The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange

Lens and metricValueScoreReading
Trend41 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-13.0%
From 52-week high-44.6%
Momentum36 · WeakLagging most stocks on this exchange.
3-month return-18.0%
6-month return-3.9%
12-month return, skipping the last month9.4%
Stability (higher is calmer)9 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)99.5%
Worst drawdown, 1 year (smaller is calmer)-59.3%
Liquidity71 · StrongTrades actively.
Average daily value traded4.94M CAD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Liquidity: Trades actively.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−19.0%
1 month−25.0%
3 months−18.0%
6 months−3.9%
1 year−18.0%
3 years−35.3%
5 years–

Signals

50-day / 200-day average13.76 / 12.38
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.72

Technical summary

DailyBearish4 bullish · 0 neutral · 12 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026